Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(27 sites)
United States
Barrow Neurological Institute, Phoenix, Arizona University of Arkansas for Medical Sciences, Little Rock, Arkansas Parkinson's Research Centers of America - Orange County, Aliso Viejo, California Parkinson's Research Centers of America - Palo Alto, Palo Alto, California Visionary Investigators Network, Aventura, Florida Parkinsons Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida Univesity of Miami - Miller School of Medicine, Boca Raton, Florida University of Miami, Miami, Florida N1 Research LLC, Orlando, Florida USF Parkinson's Disease and Movement Disorders Center, Tampa, Florida Central DuPage Hospital - Movement Disorders Center, Winfield, Illinois University of Kansas Medical Center, Kansas City, Kansas Quest Research Institute, Farmington Hills, Michigan Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada Parkinson's Research Centers of America - Long Island, Commack, New York Atrium Health Wake Forest Baptist Adult Neurology - Janeway Tower, Winston-Salem, North Carolina NeuroScience Research Center, LLC, Canton, Ohio University of Cincinnati, Cincinnati, Ohio University Hospitals Cleveland Medical Center, Cleveland, Ohio The Movement Disorder Clinic of Oklahoma, Tulsa, Oklahoma Neurology Consultants of Dallas, PA, Dallas, Texas Texas Movement Disorder Specialists, PLLC, Georgetown, Texas Icahn School of Medicine at Mount Sinai, Houston, Texas The University of Texas Health Science Center at Houston- McGovern Medical School, Houston, Texas Inova Neurology, Fairfax, Virginia VCU Parkinsons Disease and Movement Disorders Center, Henrico, Virginia MedStar Georgetown University Hospital Department of Neurology, McLean, Virginia